insitro Advances AI-Discovered CTRO-1013 for MASH With Anti-Fibrotic Data
NEW ORLEANS, June 8, 2026 insitro announced new preclinical findings from its lead metabolic dysfunction-associated steatohepatitis (MASH) program, demonstrating...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
NEW ORLEANS, June 8, 2026 insitro announced new preclinical findings from its lead metabolic dysfunction-associated steatohepatitis (MASH) program, demonstrating...
SALT LAKE CITY, Utah, June 8, 2026 Seek Labs announced a major milestone in antiviral research with the completion...
PLAINSBORO, New Jersey and BAGSVÆRD, Denmark, June 7, 2026 Novo Nordisk has reported compelling Phase 3 results demonstrating that...
VANCOUVER, British Columbia, June 2, 2026 Clarius Mobile Health has achieved a significant regulatory milestone with the U.S. Food...
SAN FRANCISCO, June 4 2026 Chai Discovery has announced a strategic license agreement with Pfizer that will enable the...
VALBY, Denmark and AMSTERDAM, Netherlands, June 3, 2026 Lundbeck and Cradle have announced a strategic partnership aimed at transforming...
REYKJAVIK, Iceland, June 4, 2026 Alvotech has announced the resubmission of U.S. Biologics License Applications (BLAs) for two important...
AMSTERDAM, Netherlands and YORK, Pa., June 4, 2026 Royal Philips and WellSpan Health have announced a landmark seven-year strategic...
CAMBRIDGE, Massachusetts, USA & PALO ALTO, California, USA, June 3, 2026 Alnylam Pharmaceuticals and Inceptive Nucleics have announced a...
WARSAW, Poland, June 3, 2026 Ingenix, an emerging artificial intelligence company focused on transforming drug discovery through advanced biological...
